Position history for BARCLAYS PLC's holdings in BRIDGEBIO PHARMA INC
BARCLAYS PLC holds 622,575 shares of BBIO (BRIDGEBIO PHARMA INC), worth $47.6M as of 2025-Q4. The position was decreased (-13.5% shares). BBIO represents 0.0% of BARCLAYS PLC's portfolio.
Current Value
$47.6M
Current Shares
622,575
Total Value Change
+$37.2M
Total Shares Change
+209,310
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 622,575 |
-13.5% |
| $47.6M |
| 0.0% |
| $75.48 |
0 |
| 2025-Q3 | Decreased | 719,448 | -22.9% | $37.4M | 0.0% | $51.96 | 0 |
| 2025-Q2 | Increased | 933,512 | +140.1% | $40.3M | 0.0% | $44.86 | 47 |
| 2025-Q1 | Decreased | 388,838 | -13.1% | $13.4M | 0.0% | $35.11 | 0 |
| 2024-Q4 | Decreased | 447,510 | -17.9% | $12.3M | 0.0% | $27.32 | 0 |
| 2024-Q3 | Increased | 545,008 | +31.9% | $13,876 | 0.0% | $24.94 | 23 |
| 2024-Q2 | Increased | 413,265 | +2.0% | $10.5M | 0.0% | $25.33 | 28 |